Review



dok2 mouse monoclonal antibody  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology dok2 mouse monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Dok2 Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/Dok-2+Antibody/pmc12456515-154-5-11
    Average 93 stars, based on 23 article reviews
    dok2 mouse monoclonal antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray"

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    Journal: Hepatology Communications

    doi: 10.1097/HC9.0000000000000807

    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Figure Legend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Techniques Used: Comparison

    Related Articles

    Comparison:

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray
    Article Snippet: Three primary antibodies were previously conjugated to metal isotopes via Maxpar Antibody Labeling Kits (Standard BioTools).Three primary antibodies were previously conjugated to metal isotopes via Maxpar Antibody Labeling Kits (Standard BioTools).. The following antibodies were used: DOK2 mouse monoclonal antibody (clone E-10; Santa Cruz Biotechnology, Inc.), CK7 mouse monoclonal antibody (clone OV-TL 12/30; Abcam, ab68459), HepPar-1 mouse monoclonal antibody (clone OCH1E5; Santa Cruz Biotechnology, Inc.).. Following antibody incubation, the slides were washed twice with 0.2% Triton X-100 in 1× PBS for 8 minutes each and then twice with 1× PBS for 8 minutes each.Following antibody incubation, the slides were washed twice with 0.2% Triton X-100 in 1× PBS for 8 minutes each and then twice with 1× PBS for 8 minutes each.



    Similar Products

    dok2 mouse monoclonal antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology dok2 mouse monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Dok2 Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/Dok-2+Antibody/pmc12456515-154-5-11
    Average 93 stars, based on 1 article reviews
    dok2 mouse monoclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mouse anti dok2 monoclonal antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse anti dok2 monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/Dok-2+Antibody/pmc12456515-139-8-15
    Average 93 stars, based on 1 article reviews
    mouse anti dok2 monoclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    primary mouse anti-dok2 monoclonal antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary mouse anti-dok2 monoclonal antibody
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Primary Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/anti+dok2/pmc04246696-49-24-34
    Average 90 stars, based on 1 article reviews
    primary mouse anti-dok2 monoclonal antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal primary antibody dok2  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse monoclonal primary antibody dok2
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Mouse Monoclonal Primary Antibody Dok2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/Dok-2+Antibody/pm22130622-77-20-26
    Average 93 stars, based on 1 article reviews
    mouse monoclonal primary antibody dok2 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mouse monoclonal anti dok2  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse monoclonal anti dok2
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Mouse Monoclonal Anti Dok2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok2+mouse+monoclonal+antibody/Dok-2+Antibody/pm22089930-77-57-91
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti dok2 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Journal: Hepatology Communications

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    doi: 10.1097/HC9.0000000000000807

    Figure Lengend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Article Snippet: The following antibodies were used: DOK2 mouse monoclonal antibody (clone E-10; Santa Cruz Biotechnology, Inc.), CK7 mouse monoclonal antibody (clone OV-TL 12/30; Abcam, ab68459), HepPar-1 mouse monoclonal antibody (clone OCH1E5; Santa Cruz Biotechnology, Inc.).

    Techniques: Comparison

    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Journal: Hepatology Communications

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    doi: 10.1097/HC9.0000000000000807

    Figure Lengend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Article Snippet: The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:25; Santa Cruz Biotechnology Inc.) or a CD68 mouse monoclonal antibody (AT1379-1; Nichirei Bioscience Inc.) for 20 minutes at 25°C.

    Techniques: Comparison

    Immunostaining for DOK2 in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Immunostaining for DOK2 in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Immunostaining

    Western blotting to detect DOK2 protein expression. Six samples were selected, four DOK-2(+) cases and two DOK2(−) cases. DOK2, docking protein 2; P, poorly-differentiated adenocarcinoma; M, moderately-differentiated adenocarcinoma.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Western blotting to detect DOK2 protein expression. Six samples were selected, four DOK-2(+) cases and two DOK2(−) cases. DOK2, docking protein 2; P, poorly-differentiated adenocarcinoma; M, moderately-differentiated adenocarcinoma.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Western Blot, Expressing

    Correlation between DOK2 expression and various clinicopathological parameters.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Correlation between DOK2 expression and various clinicopathological parameters.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Expressing

    Kaplan-Meier curves for overall survival (OS) and relapse-free survival (RFS) according to DOK2 expression. (A) OS curve and (B) RFS curve according to DOK2 expression for all patients. Differences between the two groups were evaluated by log-rank test. Ordinate survival rate, abscissa time after surgery (years). DOK2, docking protein 2.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Kaplan-Meier curves for overall survival (OS) and relapse-free survival (RFS) according to DOK2 expression. (A) OS curve and (B) RFS curve according to DOK2 expression for all patients. Differences between the two groups were evaluated by log-rank test. Ordinate survival rate, abscissa time after surgery (years). DOK2, docking protein 2.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Expressing